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SummArY – Aim. to investigate morphological findings of zero-time biopsies analyzed at the 
department of nephropathology and electron microscopy, dubrava university hospital, zagreb.
Materials and methods. The retrospective search of data was performed for the period from 2006 to 
2018. A total of 316 zero-time renal biopsies were analyzed. glomerular basement membrane (gbm) 
thickness was remeasured in 84 zero-time biopsies and 80 protocol biopsies of the same patients 12 
months after transplantation.
Results and conclusion. The acute tubular injury was present in 90% and glomerular pathology in 
17% of zero-time biopsies, with thin basement membranes (tbm) being the most common entity 
(13%). Chronic graft changes were evaluated according to banff classification. most cases showed 
banff scores ci0 (82.6%) and ct0 (65.1%). banff scores cv2 and cv3 were present in 13% and ah2 and 
ah3 in 36.4% of specimens. Among 84 remeasured zero-time samples, tbm was present in 26 pa-
tients (31%). There were no differences between banff scores and clinical parameters 12 months after 
transplantation between recipients with tbm and recipients with normal gbm thickness.
zero-time renal biopsy is of great importance for allograft assessment and comparison with con-
secutive biopsies. further investigation is needed to determine the long-term significance of tbm on 
graft survival.
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Introduction
zero-time kidney biopsies are performed at the 
time of kidney transplantation, either before or after 
perfusion of the allograft, with the purpose of assess-
ing the overall condition of the allograft so that con-
secutive biopsies can be compared to the condition of 
the allograft at the time of transplantation.1 They can 
also be used to predict the long-term function of the 
allograft, although such predictions are limited by fac-
tors such as immunosuppression toxicity or the occur-
rence of glomerular diseases.2,3 
Thin glomerular basement membrane nephropathy 
(tbmn) is the most common cause of persistent he-
maturia in children and adults, with a 1% prevalence in 
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the general population. tbmn, Alport syndrome 
(AS) and igA nephropathy together account for al-
most all causes of persistent hematuria.4-6 even though 
the main feature of tbmn is persistent microscopic 
hematuria,4,7 occasionally it can be associated with 
proteinuria.6 There are no pathological findings on 
light microscopy, while electron microscopy (em) 
shows diffuse thinning of the gbm.8 World health 
Organization (WhO) recommends a threshold for 
tbmn of 250 nm for adults and 180 nm for children 
up to 11 years of age.9 however, the referential span 
differs among laboratories, also depending on the gen-
der and the age of patients, the methodology of the 
sample preparation, and the method of measurement 
of gbm thickness. many authors state the impor-
tance of the standardization of gbm measurement 
and setup of the normal gbm thickness reference 
span for every single em laboratory.10,11
usually, tbmn represents carriers of autosomal 
recessive Alport syndrome. given that Alport spec-
trum disorders can cause renal failure, the question of 
the suitability of patients with tbmn as a kidney do-
nor arises. literature data in this area are quite scarce. 
Cases of transplantation where donors were diagnosed 
with tbmn have been described.12 to our knowledge, 
there are no specific studies, and expert opinions vary 
and range from a complete rejection of tbmn pa-
tients as donors to allowing tbmn patients as donors 
with a low risk of disease progression.13 in 2018, Choi 
et al. published a study showing 11 recipients who re-
ceived allografts from donors diagnosed with tbmn 
whose clinical data were analyzed retrospectively. The 
study involved living donors who were diagnosed with 
tbmn on a pre-transplant biopsy. recipients were 
monitored after transplant for 57.4 ± 28.6 months. 
Seven recipients had acute rejection with a median of 
9.7 months after transplantation and the renal func-
tion of all recipients recovered after treatment. One 
kidney failed due to arterial occlusion of the allograft 
and other allografts were preserved during the follow-
up period. donors were monitored for 41.0 ± 39.1 
months and subsequently contacted by telephone 
(56.8 ± 32 months in total). All donors maintained 
normal renal function during the follow-up period 
without significant complications and did not report 
any symptoms during the telephone conversation. The 
authors concluded that kidney donors with tbmn 
and their recipients have maintained renal function 
during the follow-up period and were without signifi-
cant complications and that kidney donors with 
tbmn could be a safe option for kidney transplanta-
tion.14
Methods
in the first part of this study, we have conducted a 
retrospective analysis of the data registry at the unit of 
nephropathology and electron microscopy, dubrava 
university hospital, zagreb, Croatia. data registry 
was searched by term zero-time renal transplant bi-
opsy for the period from 2006 to 2018. data about 
diagnosis and chronic graft changes according to banff 
classification were also collected.15
in the second part of the study, 90 patients were 
selected for additional investigation. The gbm thick-
ness measurement was performed using a modification 
of the gbm direct measurement method described by 
haas.10,16 The calculation of the arithmetic mean of 
these measurements at 30 sites in the glomerulus was 
made. item software, Olympus Soft imagin Solu-
tions gmbh, was used. measurements were per-
formed on x4000 - x8000 magnification digital photo-
graphs (fig. 1), using a 150 - 400% digital magnifica-
tion for more accurate positioning and measurement 
of the gbm using the distance from endothelial to the 
podocyte cell membrane. for capillary loops with the 
full range represented in digital em photography, di-
rect gbm thickness measurements were made at 3 
points of some gbm cross-section so that, assuming 
that the mesangial area is located at 12 hours, mea-
surements were made at positions closest to 3, 6 and 9 
hours, as shown in the figure 1A. for other capillaries, 
gbm measurement sites were two points of non-
oblique cross-section of the gbm closest to the edges 
of the photograph or transition to the mesangial area 
(not including the actual mesangial portion of the 
gbm). The third measurement was determined as the 
point of a nonoblique gbm section as close as possi-
ble to the midpoint (with respect to the length of the 
gbm) between the above two points (figure 1b).
The normal gbm thickness range for each gender 
was defined as the range within the previously pub-
lished referential span of normal gbm thickness for 
our laboratory (men at 268 - 412 nm and women at 
213 - 389 nm).17 The remeasured gbm thicknesses of 
84 biopsy specimens (in 6 cases there were no glom-
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Figure 1. Measurements of glomerular basement membranes (GBM) on digital photographs. A) For capillary loops 
with the full range represented in digital EM photography, direct GBM thickness measurements were made at 3 points 
of the same GBM cross-section so that, assuming that the mesangial area is located at 12 hours, measurements were 
made at positions closest to 3, 6 and 9 hours (red arrows). Original magnification x8000. B) For other capillaries, 
GBM measurement sites were two points of nonoblique cross-section of the GBM closest to the edges of the photograph 
or transition to the mesangial area (not including the actual mesangial portion of the GBM) (red arrows). The third 
measurement was determined as the point of a nonoblique GBM section as close as possible to the midpoint between the 
above two points (yellow arrow). Original magnification x8000.
Figure 2 Zero-time kidney biopsy specimen. Renal cortex 
with normal glomeruli (red arrows), artery showing mild 
fibrointimal thickening (black arrow), and tubules 
showing signs of moderate acute tubular injury  
(the loss of the brush borders and thinning of the tubular 
epithelial cells) (yellow arrows). Masson trichrome stain, 
original magnification x200.
eruli available for em analysis) zero-time biopsies 
were compared to previously described reference val-
ues for the normal thickness of gbm and the fre-
quency of exact thin glomerular basement membranes 
(tbm) in the group of zero-time biopsies was deter-
mined. We have compared the difference in the gbm 
thickness in transplanted subjects between zero-time 
biopsy and protocol biopsy performed in the same 
subject 12 months after the transplantation. Clinical 
data were collected at the department of nephrology, 
merkur university hospital, zagreb, Croatia and also 
data about chronic graft changes according to the 
banff classification15.
The data are presented textually and graphically. 
Categorical data are presented in absolute and relative 
frequencies. differences in category variables were 
tested by the χ2-square test and, if necessary, by fish-
er’s exact test. The normality of the distribution of nu-
merical variables was tested by the Shapiro - Wilk test. 
numerical data are described by the arithmetic mean 
and standard deviation and median with interquartile 
range. differences of normally distributed numerical 
variables between two independent groups were tested 
by Student’s t-test. for comparison of dependent con-
tinuous variables (on zero-time biopsy and 12 months 
post transplantation) the t-test of paired samples was 
used for normally distributed variables. for each anal-
ysis, the significance level was set to α = 0.05. All P 
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values are two-sided. The analysis was performed using 
computer programs SPSS 19.0 for Windows (SPSS 
inc., Chicago, il, uSA) and medCalc 11.4.2.0. (med-
Calc Software bvba).
All procedures in this research were in accordance 
with the helsinki declaration of 1975, as revised in 
1983. This research was approved by the ethical com-
mittee of dubrava university hospital and merkur 
university hospital.
Results
There were 316 zero-time renal biopsies. Three bi-
opsy specimens (0.9%) were inadequate for pathohis-
tological examination. median recipient age was 51 
years (range from 16 to 84 years), 204 (65%) male and 
112 (35%) female.
The most common histological diagnosis was acute 
tubular injury (figure 2), which was present in 90% of 
Figure 3 – Glomerular pathology in the zero-time kidney biopsies shown as an 
absolute number. (DN – diabetic nephropathy, DN+HN – diabetic and hypertensive 
nephropathy, TBM – thin glomerular basement membrane; IGA – IgA nephropathy, 
TMA – thrombotic microangiopathy, GN-IK- immune complex mediated 
glomerulonephritis).
Figure 4 – Chronic changes of tubulointerstitium and blood vessels in the zero-time 
kidney biopsies shown as an absolute number. Banff classification scores: ci - interstitial 
fibrosis; ct - tubular atrophy; cv - arterial fibrointimal thickening; ah - arteriolar 
hyalinosis.
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biopsies and was mainly moderate (51%), followed by 
mild (32%) and severe (17%).
in 53 (17%) biopsies, glomerular pathology was 
present. The most common entity was tbm (41, 13%), 
followed by diabetic nephropathy (7.2%) with or with-
out signs of hypertensive nephropathy, igA nephropa-
thy (3, 1%), thrombotic microangiopathy (1, 0.3%), 
and immune-complex mediated glomerulonephritis 
(1, 0.3%) as shown in figure 3.
Chronic changes of tubulointerstitium and blood 
vessels were evaluated according to banff criteria for 
chronic changes (figure 4)15. There was no interstitial 
fibrosis and tubular atrophy (ci0 and ct0) in 261 
(83.4%) and 235 (75.1%) biopsies, respectively. There 
were no arteries in 28 (8.9%) biopsy specimens. Arter-
ies showed mild fibrointimal thickening (cv1) in 34 
(11.9%), moderate (cv2) in 22 (7.7%), and severe (cv3) 
in 15 (5.3%) out of 285 specimens with arteries. mild 
arteriolar hyalinosis (ah1) was present in 41 (13.1%), 
moderate (ah2) in 71 (22.7%) and severe (ah3) in 43 
(13.7 %) of cases.
Additional analyses (remeasurement of gbm 
thickness at the zero-time biopsy and at the protocol 
biopsy 12 months post transplantation in the same pa-
tient and correlation with histological and clinical 
data) included 90 patients, median age 49 years (17 to 
73 years), 62 (68.9%) male and 28 (31.1%) female. do-
nors’ characteristics are presented in table 1. There 
were no chronic changes at zero-time biopsies in most 
patients. Scores for chronic changes according to banff 
classification15 for these 90 patients in zero-time biop-
sies are shown in table 2.
The em was performed in 84 zero-time biopsies. 
The mean value of patients’ gbm thickness in zero-
time biopsies was 268 nm, standard deviation 57 nm, 
median 266 nm with interquartile range 221 - 306 nm. 
if the measured values applied to the established refer-
ence span for our department17, tbm was present in 
26 (31%) subjects. if the WhO criterion (gbm thin-
ner than 250 nm regardless of gender) is applied, tbm 
was present in 35 (41.7%) subjects. There were no sta-
tistically significant differences (χ2 test and fisher’s 
exact test) in banff scores (ci, ct, cv, ah) on zero-time 
biopsies between patients with tbm and no tbm ac-
cording to criteria set up for our laboratory.
table 3 shows chronic changes according to banff 
classification15 in protocol biopsies 12 months after 
transplantation.
The values of gbm thickness measured on proto-
col biopsies 12 months post transplantation was avail-
able for 80 out of 90 patients. The mean value was 
256.5 nm, standard deviation 44.8 nm, median 258 
nm, interquartile range 229 - 286 nm. if the measured 
values applied to the established reference span for our 
department17, tbm was present in 25 (31.3%) sub-
jects. if the WhO criterion (gbm thinner than 250 
nm regardless of gender) is applied, tbm was present 
in 34 (42.5%) subjects.
Table 1. Kidney donors’ characteristics.
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We compared gbm thickness on zero-time biopsy 
with values measured on protocol biopsy in the same 
patients 12 months post transplantation. no statisti-
cally significant difference (p>0.05) in gbm thickness 
was found (paired sample t-test).
mean value of the estimated glomerular filtration 
rate for patients 12 months after transplantation was 
55.76 ml/min/1.73m2, standard deviation 17.09 ml/
min/1.73m2, median 55.76 ml/min/1.73m2 with inter-
quartile range 44.90 – 65.85 ml/min/1.73m2. Clinical 
data about proteinuria was available for 78 patients 
and hematuria for 77 patients. Proteinuria was present 
in 10 (12.8%) patients and hematuria in 7 (9.1%). 
There was no statistically significant difference be-
tween subjects with and without tbm on their proto-
col biopsies 12 months post transplantation in pro-
teinuria, hematuria, estimated glomerular filtration 
rate (χ2 test, Student t-test), and banff chronic scores: 
ci, ct, cv, ah (fisher’s exact test).
Discussion
zero-time kidney biopsies are performed at the 
time of kidney transplantation, either before or after 
the perfusion of the allograft, with the purpose of as-
sessing the overall condition of the allograft so that 
consecutive biopsies can be compared to the condition 
of the allograft at the time of transplantation.1 Certain 
abnormalities are often found during the pathohisto-
logical assessment of zero-time kidney biopsies. A very 
common finding is nephroangiosclerosis due to hyper-
tension. nickleit et al.1 reported nephroangiosclerosis 
to be present in 68% of allograft, 19% of which were 
moderate or severe. in our study, arteries showed mild 
fibrointimal thickening (cv1) in 34 (11.9%) and mod-
erate (cv2) or severe (cv3) in 37 (13%) zero-time biop-
sies. mild arteriolar hyalinosis (ah1) was present in 41 
(13.1%) and moderate (ah2) or severe (ah3) in 114 
(36.4%) zero-time biopsies.
There are also other subclinical disorders in donor 
kidneys. igA deposition was present in 9 - 11% of liv-
ing donor biopsies.18,19 Prevalence of igA nephropathy 
in our study was low and was present in 1% of zero-
time biopsy specimens. This kind of lower percentage 
could be explained by the fact that zero-time speci-
mens were received fixed in formalin and the immuno-
fluorescent analysis on paraffin embedded tissue was 
Table 2. Chronic changes scores according to Banff classification15 in zero-time biopsies  
for 90 reanalyzed patients.
Chronic changes according to banff classification15
banff score ci ct cv ah
0 68 (75.6%) 62 (68.9%) 66 (73.3%) 44 (48.9%)
1 20 (22.2%) 27 (30%) 9 (10%) 14 (15.5 %)
2 2 (2.2%) 1 (1.1%) 7 (7.8%) 16 (17.8%)
3 0 (0%) 0 (0%) 7 (7.8%) 16 (17.8%)
X 0 (0%) 0 (0%) 1 (1.1%) 0 (0%)
X- analysis not possible – no arteries, ci - interstitial fibrosis score, ct - tubular atrophy score,
cv – arterial fibrous intimal thickening score, ah - arteriolar hyalinosis score
Table 3. Chronic changes scores according to Banff classification15 in biopsies 12 months after 
transplantation for 90 reanalyzed patients.
Chronic changes according to banff classification15
banff score ci ct cv ah
0 31 (34.4%) 21 (23.3%) 65 (72.2%) 40 (44.4%)
1 41 (45.6%) 51 (56.7%) 11 (12.2%) 12 (13.3%)
2 14 (15.6%) 14 (15.6%) 6 (6.7%) 24 (26.7%)
3 4 (4.4%) 4 (4.4%) 8 (8.9%) 14 (15.6%)
ci - interstitial fibrosis score, ct - tubular atrophy score, cv – arterial fibrous intimal thickening score,
ah - arteriolar hyalinosis score
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performed only if glomerular abnormalities on light 
microscopy and/or em were found. 
A diffuse thinning of gbm on em should be pres-
ent for tbmn diagnosis. however, determining the 
presence of diffuse thinning of gbm could be prob-
lematic. Primarily, there are no standard criteria for de-
fining the normal span of gbm thickness or lower 
threshold below which gbm can be considered thin, 
and there is also a significant variability among those 
values determined at different centers. A potential 
problem in diagnosing tbmn is the methodology for 
measuring gbm on em images. gbm thickness var-
ies depending on gender and age. Also, the methodol-
ogy of preparation of samples for the analysis greatly 
influences the thickness of gbm. The normal span of 
gbm thickness varies in centers of excellence and lit-
erature citations. given the variability of gbm thick-
nesses among laboratories, several authors emphasized 
the necessity of defining their own normal span of 
gbm thickness.10,11 Variability is also related to the 
methodology of gbm thickness measurement. 
dische,20 using the orthogonal intersection method/
mean harmonic thickness of gbm measurements,21 
established a normal span of gbm thickness in adults 
from 330 to 460 nm, with the definition of tbmn as 
an average gbm thickness of less than 330 nm. using 
a similar methodology, tiebosch et al.22 established the 
lower threshold of the normal gbm thickness at 264 
nm. Apart from the random sampling of the gbm 
cross-section, the advantages of this method are that it 
gives a normal distribution of gbm thickness and that 
the results are reproducible when the same glomerulus 
is re-photographed.20 The main disadvantage is that it 
is extremely time-consuming to be used in most labo-
ratories for diagnostic pathology.10 An alternative is the 
method of direct measurement of gbm thickness (dis-
tance from endothelial to podocyte cell membrane) and 
assessing the arithmetic mean of these measurements. 
This method is easily applied in diagnostic laboratories 
without a specialized camera or software, although it 
excludes obliquely truncated areas of the gbm and 
shows a tendency to give lower normal gbm thickness 
spans than the orthogonal intersection/mean harmonic 
thickness method.16,23-25 das et al.24 found that if 16 
measurements from each of the two glomeruli were 
performed by this method, results could be reproduced 
on the same results obtained using the orthogonal in-
tersection/mean harmonic thickness method, although 
values were approximately 40% higher if the latter 
method was performed.24 
in our department’s routine clinical work, we have 
noticed the appearance of thin gbm in em findings of 
zero-time kidney biopsies.26 routinely em is per-
formed on zero-time kidney biopsy specimens and 
gbm thickness is measured on at least 10 random 
places using em JeOl 1400 and item software, 
Olympus Soft imagin Solutions gmbh using direct 
measurement/arithmetic mean measurement method. 
The number and place of measurement were not stan-
dardized until recently. Thus, the aim of the second part 
of our study with an examination of 84 zero-time kid-
ney biopsies was to determine the frequency of tbm 
when gbm thickness was measured with a standard-
ized method and to examine clinical characteristics of 
such subjects. According to the reference span for our 
department (normal gbm thickness range set for men 
at 268-412 nm and women at 213-389 nm)17, tbm 
was present in 26 (31%) subjects in a zero-time biopsy, 
while according to the WhO reference span (gbm 
thinner than 250 nm regardless of gender), thin gbm 
was present in 35 (41,7 %) subjects.
literature data on potential kidney donors with 
tbmn is quite scarce. Cases of transplant where do-
nors were diagnosed with tbmn have been de-
scribed.12 dische et al. described in newly transplanted 
allograft kidneys five out of 76 donor kidneys who had 
tbm, and in two additional cases, the measurements 
of gbm were in the range between thin and normal.7
hassan et al.27 described tbmn in 13 of 45 (28.9%) 
subjects. it is important to note that these were kidney 
biopsies of potential living kidney donors who had iso-
lated microscopic hematuria. Choi et al.28 reported the 
presence of tbmn in 7 of 15 patients undergoing kid-
ney biopsy for donation suitability assessment. This data 
from the literature and the data from our study in which 
the tbm was found in 31% zero-time kidney biopsies 
are surprisingly high, given that the literature often cites 
the prevalence of tbmn in the general population of 
1%, and our study consisted of zero-time biopsies of 
kidney allografts rather than selected cohort with as-
ymptomatic patients with disorders in urine analysis.16,29 
interestingly, a study by Choi et al.14 from 2018 
showed that only 2 allografts of 11 kidneys analyzed 
before transplantation and diagnosed with tbmn 
showed tbmn in protocol biopsy 10 days after trans-
plantation. in recipients of two allografts who had 
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tbmn on protocol biopsy 10 days after transplanta-
tion, one recipient had normal gbm thickness on 
protocol biopsy one year after transplantation while 
the other showed type iiA acute cellular rejection with 
irregular thickening of the gbm 6 years after trans-
plantation. The other 9 recipients had normal gbm 
thickness in the protocol or indication biopsies averag-
ing 11,0 ± 11,4 months after transplantation. There 
was no statistically significant difference in gbm 
thickness between zero-time biopsies and protocol bi-
opsies 12 months after transplantation in the same pa-
tients in our study.
We found a surprisingly high prevalence of tbm 
in zero-time and protocol biopsies 12 months after 
transplantation in the same patients, but with no dif-
ference in proteinuria, hematuria, and estimated glo-
merular filtration rate between subjects with and with-
out tbm 12 months after transplantation.
hematuria in transplant subjects is most frequently 
caused by urinary tract infections, followed by renal 
neoplasms, graft rejection, recurrence of the underlying 
disease, and urolithiasis.30 dische et al. stated that there 
were factors that could affect gbm measurement re-
sults, such as cerebrovascular accident, which might be 
suspected of having a pathogenetic association with 
thin gbm, technical factors such as warm and cold 
ischemia of the graft and tissue fixation.7 in the process 
of measurement standardization, a normal gbm thick-
ness reference span was created at our department.17 
Considering our reference span of normal gbm thick-
ness similar to one described by haas10,16, we believe our 
morphometric method should be satisfactory.
further research on a larger number of zero-time 
biopsies with the gathering of additional follow up 
data are planned to confirm our results on a larger 
specimen. We plan to additionally investigate whether 
the gbm thickness of zero-time biopsies influences 
long term graft survival.
Acknowledgment
This research was done as a part of a project enti-
tled ‘’genotype-Phenotype correlation in Alport’s 
syndrome and Thin glomerular basement membrane 
nephropathy’’ (iP-2014-09-2151) funded by the Cro-
atian Science foundation.
We would like to thank all our transplant col-
leagues for long-standing collaboration.
The authors have no conflict of interest to declare.
References
 1. nickeleit V, mengel m, Colvin rb. renal transplant Pathol-
ogy. in: Jennette JC, Olson Jl, Silva fg, d’Agati Vd, eds. 
heptinstall’s pathology of the kidney. 7th ed. Philadelphia: 
Wolters Kluwer health/lippincott Williams & Wilkins; 
2015:1321-459.
 2. de Vusser K, lerut e, Kuypers d, Vanrenterghem Y, Jochmans 
i, monbaliu d, et al. The predictive value of kidney allograft 
baseline biopsies for long-term graft survival. J Am Soc 
nephrol. 2013;24:1913-23. doi:10.1681/ASn.2012111081
 3. nickeleit V. Pathology: donor biopsy evaluation at time of renal 
grafting. nat rev nephrol. 2009;5:249-51. doi:10.1038/nrne-
ph.2009.50
 4. Savige J, rana K, tonna S, buzza m, dagher h, Wang YY. 
Thin basement membrane nephropathy. Kidney int. 2003; 
64:1169-78. doi:10.1046/j.1523-1755.2003.00234.x
 5. Kashtan Ce. familial hematuria due to type iV collagen muta-
tions: Alport syndrome and thin basement membrane ne-
phropathy. Curr Opin Pediatr. 2004;16:177-81. doi:00008480-
200404000-00011
 6. gregory mC. The clinical features of thin basement membrane 
nephropathy. Semin nephrol. 2005;25:140-5. doi:10.1016/j.
semnephrol.2005.01.004
 7. dische fe, Anderson Ve, Keane SJ, taube d, bewick m, Par-
sons V. incidence of thin membrane nephropathy: morpho-
metric investigation of a population sample. J Clin Pathol. 
1990;43:457-60. doi:10.1136/jcp.43.6.457.
 8. foster K, markowitz gS, d’Agati Vd. Pathology of thin base-
ment membrane nephropathy. Semin nephrol. 2005;25:149-
58. doi:10.1016/j.semnephrol.2005.01.006
 9. Churg J. renal disease : classification and atlas of glomerular 
diseases. tokyo: igaku-Shoin; 1982.
10. haas m. Alport syndrome and thin glomerular basement 
membrane nephropathy: a practical approach to diagnosis. 
Arch Pathol lab med. 2009;133:224-32. doi:10.1043/1543-
2165-133.2.224
11. tryggvason K, Patrakka J. Thin basement membrane nephrop-
athy. J Am Soc nephrol. 2006;17:813-22. doi:10.1681/
ASn.2005070737
12. Sakai K, muramatsu m, Ogiwara h, Kawamura t, Arai K, Ai-
kawa A, et al. living related kidney transplantation in a patient 
with autosomal-recessive Alport syndrome. Clin transplant. 
2003;17 Suppl 10:4-8. doi:10.1034/j.1399-0012.17.s10.5.x
13. ierino fl, Kanellis J. Thin basement membrane nephropathy 
and renal transplantation. Seminars in nephrology. 2005;25: 
184-7. doi:10.1016/j.semnephrol.2005.01.012
14. Choi C, Ahn S, min SK, ha J, Ahn C, Kim Y, et al. midterm 
Outcome of Kidney transplantation from donors With Thin 
basement membrane nephropathy. transplantation. 2018; 
102:e180-e4. doi:10.1097/tP.0000000000002089
15. loupy A, haas m, Solez K, racusen l, glotz d, Seron d, et 
al. The banff 2015 Kidney meeting report: Current Chal-
P. Šenjug et al. Significance of zero-time renal transplant biopsies and thin glomerular basement membranes
Acta Clin Croat, Vol. 60, (Suppl. 1) 2021 141
lenges in rejection Classification and Prospects for Adopting 
molecular Pathology. Am J transplant. 2017;17:28-41. doi: 
10.1111/ajt.14107
16. haas m. Thin glomerular basement membrane nephropathy: 
incidence in 3471 consecutive renal biopsies examined by elec-
tron microscopy. Arch Pathol lab med. 2006;130:699-706. 
doi:10.1043/1543-2165(2006)130[699:tgbmni]2.0.CO;2
17. Šenjug P, Krištić A, bauer Šegvić A, bacalja J, bulimbašić S, 
galešić ljubanović d. Standardization of measurement and 
determination of normal glomerular basement membrane 
thickness at department of Pathology and Cytology, dubrava 
university hospital, zagreb. Virchows Archiv. 2015;467 (Sup-
plement 1):33-4. doi:10.1007/s00428-015-1805-9.
18. rosenberg hg, martinez PS, Vaccarezza AS, martinez lV. 
morphological findings in 70 kidneys of living donors for renal 
transplant. Pathol res Pract. 1990;186:619-24. doi:10.1016/
S0344-0338(11)80225-6
19. Cosyns JP, malaise J, hanique g, mourad m, baldi A, goeb-
bels rm, et al. lesions in donor kidneys: nature, incidence, and 
influence on graft function. transpl int. 1998;11:22-7. doi: 
10.1007/s001470050097
20. dische fe. measurement of glomerular basement membrane 
thickness and its application to the diagnosis of thin-mem-
brane nephropathy. Arch Pathol lab med. 1992;116:43-9.
21. hirose K, Osterby r, nozawa m, gundersen hJ. develop-
ment of glomerular lesions in experimental long-term diabetes 
in the rat. Kidney int. 1982;21:689-95. doi:10.1038/ki.1982.82
22. tiebosch At, frederik Pm, van breda Vriesman PJ, mooy Jm, 
van rie h, van de Wiel tW, et al. Thin-basement-membrane 
nephropathy in adults with persistent hematuria. n engl J 
med. 1989;320:14-8. doi:10.1056/neJm198901053200103
23. mclay Al, Jackson r, meyboom f, Jones Jm. glomerular 
basement membrane thinning in adults: clinicopathological 
correlations of a new diagnostic approach. nephrol dial trans-
plant. 1992;7:191-9. doi:10.1093/oxfordjournals.ndt.a092104
24. das AK, Pickett tm, tungekar mf. glomerular basement 
membrane thickness - a comparison of two methods of mea-
surement in patients with unexplained haematuria. nephrol 
dial transplant. 1996;11:1256-60.
25. Abe S, Amagasaki Y, iyori S, Konishi K, Kato e, Sakaguchi h, 
et al. Thin basement membrane syndrome in adults. J Clin 
Pathol. 1987;40:318-22. doi:10.1136/jcp.40.3.318
26. horaček m, Šenjug P, Knotek m, d gl. Clinical significance 
of zero-time renal transplant biopsies. Virchows Archiv. 2019; 
473 (Suppl 1):1-340. doi:10.1007/s00428-019-02631-8
27. hassan eA, Ali tz, Abdulbaki A, ibrahim iA, Almanae hm, 
Aleid hA. histopathologic findings of Potential Kidney do-
nors With Asymptomatic microscopic hematuria: impact on 
donation. transplant Proc. 2017;49:1729-32. doi:10.1016/j.
transproceed.2017.05.010
28. Choi Sr, Sun iO, hong YA, Kim hg, Park hS, Chung bh, 
et al. The role of kidney biopsy to determine donation from 
prospective kidney donors with asymptomatic urinary ab-
normalities. transplant Proc. 2012;44:11-3. doi:10.1016/j.
transproceed.2011.12.008
29. gubler m, heidet l, Antignac C. Alport’s syndrome, thin 
basement membrane nephropathy, nail-patella syndrome, and 
type iii collagen glomerulopathy. in: Jennette JC, heptinstall 
rh, eds. heptinstall’s pathology of the kidney. 6th ed. Phila-
delphia, PA: lippincott Williams & Wilkins; 2007.
30. Wang z, Vathsala A, tiong hY. haematuria in postrenal 
transplant patients. biomed res int. 2015;2015:292034. doi: 
10.1155/2015/292034
Sažetak
KliniČKO znAČenJe nultih biOPSiJA trAnSPlAntirAnih bubregA  
i tAnKih glOmerulArnih bAzAlnih membrAnA  
u nultim biOPSiJAmA trAnSPlAntirAnih bubregA
P. Šenjug, M. Horaček, B. Maksimović, K. Vučur, I. Horvatić, N. Zagorec, M. Knotek i D. Galešić Ljubanović
Cilj. ispitati morfološke karakteristike nultih biopsija bubrega analiziranih na Odjelu za nefropatologiju i elektronsku 
mikroskopiju Kliničke bolnice dubrava, zagreb.
Materijali i metode. retrospektivno pretraživanje podataka provedeno je za razdoblje od 2006. do 2018. godine. Analizi-
rano je ukupno 316 nultih biopsija bubrega. debljina glomerularne bazalne membrane (gbm) ponovno je izmjerena u 84 
nulte i 80 protokolarnih biopsija istih pacijenata 12 mjeseci nakon transplantacije.
Rezultati i zaključak. Akutno tubularno oštećenje bilo je prisutno u 90% nultih biopsija, a u 17% biopsija pronađena je 
glomerularna patologija, od toga je najčešći entitet bio tanke bazalne mebrane (tbm) (13%). Kronične promjene presatka 
procijenjene su prema banff klasifikaciji. Većina slučajeva pokazala je banff skorove ci0 (82,6%) i ct0 (65,1%). banff skorovi 
cv2 i cv3 bili su prisutni u 13%, a ah2 i ah3 u 36,4% uzoraka. među 84 ponovno izmjerenih nultih biopsija tbm su bile 
prisutne u 26 pacijenata (31%). nije bilo razlika između banff skorova i kliničkih parametara 12 mjeseci nakon transplanta-
cije između primatelja s tbm i primatelja s normalnom debljinom gbm.
nulte biopsije bubrega su iznimno važne za procjenu presatka i usporedbu s kasnijim protokolarnim biopsijama. Kako bi 
se utvrdio dugoročni značaj tbm-a na preživljavanje presatka potrebna su dodatna istraživanja.
Ključne riječi: nulte biopsije bubrega, glomerularna bazalna membrana, tanka bazalna membrana
